April 13, 2010 (FinancialWire) — China VoIP & Digital Telecom, Inc.'s (OTCBB: CVDT) wholly-owned subsidiary Jinan Yinquan Technology Co., Ltd, said that it has signed an agreement with Qilu Pharmaceutical Co., Ltd. to launch its integrated datacenter virtualization solution.
Virtualization is a software technology designed to make it possible to run multiple operating systems and multiple applications on the same computer at the same time, increasing the utilization and flexibility of hardware.
China-based Qilu Pharmaceutical is a large-scale pharmaceutical company that mainly engages in development, production and sale of the preparation and drug substances for the treatment of cancer, the diseases related with cardiovascular and cerebrovascular, infections, mental nervous system, respiratory system, digestive system, and ophthalmology.
The firm’s sales coverage includes China, Europe, North America, South America and East Asia.
China-based China VoIP & Digital Telecom offers virtualization technology application in China through its wholly owned subsidiary Jinan Yinquan Technology Co., Ltd and Beijing PowerUnique Technologies, Co., Ltd.
FinancialWire(tm) is committed to serving the financial community through true journalism and providing relevant resources to investors. Standards-based, independent equity research on numerous public companies is available through the Investrend Research Syndicate (http://www.investrend.com/reports) written by FIRST Research Consortium (http://www.investrend.com/FIRST) member-providers. Free annual reports and company filings for companies mentioned in the news are available through the Investrend Information Syndicate (at http://investrend.ar.wilink.com/?level=279). FinancialWire(tm), in cooperation with the Investrend Broadcast Syndicate, also provides complete, daily conference call and webcast schedules as a service to shareholders and investors via the FirstAlert(tm) Network’s “FirstAlert(tm) Daily” (http://www.financialwire.net/news-alerts/).
FinancialWire(tm) is a fully independent, proprietary news wire service. FinancialWire(tm) is not a press release service, and receives no compensation for its news, opinions or distributions. Further disclosure is at the FinancialWire(tm) website (http://www.financialwire.net/disclosures.php). Contact FinancialWire(tm) directly via inquiries@financialwire.net.
[hlmsmlh] [infrntntchnlgy] [chnchn] [biomedphrm] [prtnrshpsphs]